First look at Verve study data offer base editing 'proof of principle' | BioPharma Dive

Retrieved on: 2023-11-12 20:42:47

Tags for this article:

Click the tags to see associated articles and topics

First look at Verve study data offer base editing 'proof of principle' | BioPharma Dive. View article details on hiswai:

Excerpt

Early clinical trial results showed Verve's therapy can substantially lower cholesterol levels by editing the genes of liver cells. Published Nov.

Article found on: www.biopharmadive.com